http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
IMAX reports $43.6 million opening weekend for Avatar: Fire and Ash
-
Vivos Inc Summarzes Preogress in its Animal Therapy Division
-
Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)
-
IMAX Soars to Top Five All-Time Global Opening with $43.6 Million Debut of James Cameron’s “Avatar: Fire and Ash”
-
TerraMaster TOS System 15th Anniversary Milestone: TOS 7 Beta Now Open Worldwide
-
Gilead exercises option for Assembly Bio's herpes treatment programs
-
Nasus Pharma outlines 2026 clinical milestones for NS002 epinephrine
-
Nasus Pharma CEO Issues 2025 Letter to Shareholders
-
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
-
Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA
-
Toshiba & Partners Donate $114,000 to Help Veteran & Youth Causes
-
Ascendiant Capital Markets: “Society Pass Inc (Nasdaq: SOPA) stock is undervalued and should be higher on NusaTrip valuation”
-
Progress on Great American Rail-Trail Builds with New Miles and $30 Million in New Funding in 2025
-
DeFi Technologies clarifies share ownership issues, director resigns
-
DeFi Technologies Provides Clarifying Update on Share Ownership and Depository Imbalances and Outlines Next Steps and Announces Resignation of Director
-
Coppernico Provides 2025 Recap and Outlook for 2026
-
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
-
GFG Receives Final Payment from the Sale of its Rattlesnake Hills Gold Project
-
Greenwich LifeSciences reports progress on FLAMINGO-01 breast cancer trial
-
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
-
CoinEx's 2025 Annual Report: No More 4-Year Cycle – Navigating the Institution-Dominated Crypto Era
-
CoinEx's 2025 Annual Report: No More 4-Year Cycle – Navigating the Institution-Dominated Crypto Era
-
Bitcoin’s Early Gains Are History Apeing’s Whitelist Positions It as the Next 1000x Crypto
-
CoinEx Reinforces Safety and Trust Through Proof of Reserve in December 2025
-
Argo Graphene Solutions Reports 56-Day Compressive Strength Test Confirms 25% Total Increase in Graphene-Infused Concrete
-
ROBOFOREX EARNS DUAL AWARDS AT THE GLOBAL BRAND AWARDS 2025
-
JBD Launches "Roadrunner I" Polychrome Projector, Setting a New Benchmark for AR Color Displays with a 2.5μm Pixel Pitch
-
ZeroAvia Completes Financing Round
-
HYCU® Partners with VSTECS as Regional Distributor to Accelerate Modern Data Protection Across Asia-Pacific
-
7 Fast-Moving Altcoins Capture Market Attention as One Shapes Up as Next 1000x Crypto Presale
-
ROM: Golden Age on CROSS Officially Onboarded to the CROSS Blockchain Platform
-
Blazpay Surges Into the Spotlight After Audit Clears All Critical Risks, Pushing the AI Crypto Presale Beyond the $2.04M Milestone
-
Golden Matrix Group Appoints Atul Bali, Gaming Industry Expert, as Non-Executive Director
-
Frost & Sullivan Recognizes Best-in-Class Manufacturers & Sustainability Leaders at the 2025 India Manufacturing Excellence Awards (IMEA) & Sustainability 4.0 Awards
-
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
-
Aclaris Therapeutics added to NASDAQ Biotechnology Index
-
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
-
MAKING SPIRITS BRIGHT: THE SANDALS FOUNDATION LEADS ITS LARGEST TOY DRIVE TO DATE, DONATING 45,000 TOYS ACROSS THE CARIBBEAN
-
Jeep® Brand Adds Sahara Trim to Gladiator Lineup for the First Time, Combining Rugged Capability with Premium Everyday Comfort at Exceptional Value
-
Merck agrees with US government to expand medicine access and cut costs
-
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
-
Novartis and US government reach agreement on lowering drug prices in the US
-
GILEAD reaches three-year pricing agreement with US government
-
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
-
Why Enterprise AI Needs an Execution Layer, Not Another Copilot
-
Morgan Stanley seen as front-runner for SpaceX IPO, sources say
-
The Donald M. Ephraim Sun & Stars International Film Festival© To Honor PB County Film Commissioner Michelle Hillery with Inaugural 'Ephraim/Sriberg Award for Cinematic Excellence'
-
AmeraMex Announces $413,000 in New Equipment Orders
-
L'OFFICIEL Launches a Remarkable Global Project Featuring Jay Chou on the Covers of L'OFFICIEL HOMMES Across Seven Countries and Regions
-
TGE, Subsidiary of AMTD Digital, Announces Successful Pricing of First SPAC Listing

